DEFR14A: TETE Seeks 6-Month Extension for Business Combination

Technology & Telecommunication Acquisition Corporation (TETE) is seeking shareholder approval to extend its business combination deadline by six months to February 20, 2026, to finalize a merger with Bradbury Capital Holdings Inc.

Summary

• TETE, a Special Purpose Acquisition Company (SPAC), is holding an Extraordinary General Meeting on August 20, 2025, to vote on extending its business combination deadline.
• The current deadline to complete a business combination is August 20, 2025, and the proposed extension would move this deadline to February 20, 2026.
• This extension is deemed necessary by the board to allow sufficient time to hold a shareholder vote and consummate the proposed business combination with Bradbury Capital Holdings Inc.
• Shareholders will vote on three proposals: the Extension Amendment Proposal, the Trust Agreement Amendment Proposal, and the Adjournment Proposal.
• The company has a history of multiple extensions, with previous approvals on January 18, 2023 (to July 20, 2023), July 18, 2023 (to July 20, 2024), June 7, 2024 (to January 20, 2025), January 20, 2025 (to April 20, 2025), and April 16, 2025 (to August 20, 2025).
• Significant shareholder redemptions have occurred during previous extension votes, including $86,353,662 on January 18, 2023, $1,626,736.79 on July 18, 2023, $4,872,513.12 on June 7, 2024, $24,739,495.83 on January 20, 2025, and $45,060.56 on April 16, 2025.
• As of May 31, 2025, the Trust Account held approximately $7,258,933, with 570,982 Public Shares outstanding.
• The redemption price per Public Share was approximately $12.71 as of May 31, 2025, which was higher than the closing price of $12.00 on the OTC Pink Market on May 30, 2025.
• The Sponsor has loaned an aggregate of $2,817,736 for extension payments as of May 31, 2025, which are convertible into 281,773 TETE Units at $10.00 per unit upon business combination.

Sentiment

Score: 3

Explanation: The company is struggling to complete its business combination, evidenced by repeated extensions, significant shareholder redemptions, and delisting from Nasdaq. While a definitive agreement exists, the ongoing delays and financial implications for public shareholders (market price below redemption value) indicate a challenging outlook. The reliance on sponsor loans for extensions also points to financial strain.

Positives

• The board of directors believes the proposed extension is in the best interests of shareholders to allow sufficient time to complete a business combination.
• A definitive agreement for a proposed business combination with Bradbury Capital Holdings Inc. has been entered into, indicating a potential target.
• Non-redemption agreements were executed with the Sponsor and certain institutional investors in January and April 2025 to mitigate redemptions, demonstrating efforts to retain capital.

Negatives

• The company's repeated need for extensions (this being the sixth request) indicates persistent difficulties in consummating a business combination within initial timelines.
• Significant shareholder redemptions at each prior extension vote have drastically reduced the Trust Account balance and the number of Public Shares outstanding.
• The company's securities were delisted from Nasdaq on January 23, 2025, and now trade on the OTC Pink Market, leading to reduced liquidity, limited market quotations, and decreased investor visibility.
• The current market price of $12.00 per Public Share is lower than the redemption price of approximately $12.71, suggesting that shareholders could receive less by selling in the open market than by redeeming their shares.
• There is a significant risk of liquidation if the extension proposals are not approved or if the business combination is not consummated by the extended deadline, which would render warrants worthless and founder shares valueless.

Risks

• **Investment Company Act Applicability**: The company faces a risk of being deemed an unregistered investment company under the Investment Company Act of 1940, which could force liquidation and cause warrants to expire worthless.
• **U.S. Foreign Investment Regulations (CFIUS)**: As the Sponsor is controlled by a Malaysian citizen, an initial business combination with a U.S. target company may be subject to review by the Committee on Foreign Investment in the United States (CFIUS), potentially blocking or delaying the transaction.
• **Delisting Consequences**: The delisting from Nasdaq and trading on the OTC Pink Market results in limited market quotations, reduced liquidity for securities, limited news and analyst coverage, and a decreased ability to issue additional securities or obtain financing.
• **Failure to Complete Business Combination**: There is a significant risk that the company will not be able to complete a business combination by the extended deadline, which would lead to liquidation and the loss of investment opportunity for shareholders.
• **Shareholder Redemptions**: High redemption rates during extension votes can further deplete the Trust Account, making the company less attractive to potential target businesses and increasing the percentage interest of the Sponsor and its affiliates.
• **Liquidity Risk**: Shareholders may face difficulty selling their Ordinary Shares in the open market due to insufficient liquidity, especially if the market price is below the redemption price.
• **Dilution**: If the extension is implemented and redemptions occur, the percentage interest of the company held by its officers, directors, the Sponsor, and its affiliates will increase.

Future Outlook

The company intends to continue its efforts to consummate a business combination with Bradbury Capital Holdings Inc. by the proposed extended date of February 20, 2026. A separate extraordinary general meeting will be held at a future date to approve the business combination itself.

Management Comments

• Our board of directors currently believes that there will not be sufficient time before August 20, 2025 to hold a general meeting at which to conduct a vote for shareholder approval of the Proposed Business Combination.
• Our board of directors has determined it is in the best interests of the Company and our shareholders to extend the termination date from August 20, 2025 to the Extended Date.
• Without the Extension, there is significant risk that TETE will not, despite its best efforts, be able to complete a Business Combination on or before the Termination Date.
• TETE believes a Business Combination will provide significant benefits to its shareholders.
• The Board unanimously recommends that you vote or give instruction to vote FOR such proposals.

Industry Context

This filing reflects a common challenge faced by Special Purpose Acquisition Companies (SPACs) in the current market environment, where completing a de-SPAC transaction within initial timelines is increasingly difficult. The repeated need for extensions and significant shareholder redemptions are indicative of broader market skepticism and increased investor scrutiny of SPACs, particularly those that have been delisted from major exchanges. The CFIUS risk highlights the complexities of cross-border M&A, especially for SPACs with foreign sponsors targeting U.S. businesses.

Comparison to Industry Standards

• The repeated extensions and high redemption rates are worse than industry standards for successful SPACs, which typically aim to complete a business combination within 18-24 months with lower redemption rates.
• The delisting from Nasdaq to the OTC Pink Market is a significant negative deviation from industry standards for publicly traded companies, impacting liquidity and investor confidence.
• The market price of $12.00 per share being below the redemption price of $12.71 suggests a lack of market confidence in the company's ability to successfully complete its business combination and generate future value, a common trend for struggling SPACs.
• The reliance on Sponsor loans for extension payments is a common SPAC mechanism but, when coupled with high redemptions, indicates a dwindling trust account and increased financial strain.

Corporate Governance

Related Party Transactions

• The Sponsor has loaned the company an aggregate of $2,817,736 for extension payments as of May 31, 2025, convertible into 281,773 TETE Units at $10.00 per unit upon business combination.
• Non-Redemption Agreements were entered into with the Sponsor and certain institutional investors on January 20, 2025, and April 14, 2025, where investors agreed not to redeem shares in exchange for potential future share forfeitures by the Sponsor or cash payments from the trust account.
• Directors and officers have interests in the extension proposals, including ownership of Founder Shares (2,875,000 shares) and private placement units (532,500 units) which would be worthless if the company liquidates.

Stakeholder Impact

• **Shareholders**: Public shareholders have redemption rights, but the market price is currently below the redemption value. Failure to extend or complete a business combination would lead to liquidation and warrants expiring worthless. Continued redemptions increase the percentage ownership of the Sponsor and its affiliates.
• **Sponsor/Insiders**: Have a significant financial interest in the extension and completion of a business combination, as their founder shares and private placement units would become worthless upon liquidation. They have provided loans for extensions.
• **Bradbury Capital Holdings Inc.**: The target company's merger is contingent on TETE's ability to secure this extension and ultimately complete the business combination.
• **Creditors**: In case of liquidation, the company has obligations under the Companies Act to provide for claims of creditors.

Next Steps

• Hold an Extraordinary General Meeting on August 20, 2025, to vote on the extension proposals.
• If approved, file amended and restated Articles of Association with the Cayman Islands Registrar of Companies.
• Continue efforts to consummate a business combination with Bradbury Capital Holdings Inc. by February 20, 2026.
• Call a separate Business Combination Extraordinary General Meeting at a future date to approve the actual merger.
• If proposals are not approved and no further extensions, the company will liquidate.

Key Dates

Recommendation

Given the company's history of multiple extensions, significant shareholder redemptions, and delisting from Nasdaq, the ability to successfully complete a value-accretive business combination remains highly uncertain. The current market price being below the redemption value suggests a lack of confidence. While the board recommends the extension, the persistent challenges and the risk of liquidation if the business combination fails make this a high-risk investment. A seasoned investor would likely consider exiting to preserve capital, especially given the availability of redemption at a higher price than the current market value, or would have already done so in previous redemption windows.

Keywords

SPAC, Technology & Telecommunication Acquisition Corporation, TETE, Bradbury Capital Holdings Inc., Business Combination, Extension, Proxy Statement, Shareholder Meeting, Redemption Rights, Trust Account, DEFR14A, SEC Filing, Corporate Governance, Delisting, OTC Markets, CFIUS, Investment Company Act